London, UK, 19 December 2006: BioProgress plc ('BioProgress' or the 'Company') (AIM: BPRG; NASDAQ: BPRG), the speciality pharma and healthcare company, today announces the launch of two new products within its US portfolio through its subsidiary Dexo LLC. The Company also announces the placement of its first production TabWrap™ system into a fully compliant pharmaceutical manufacturing facility.
